Should I Buy ATS? ATS 2026 Analysis - Intellectia AI™

Loading...

Should You Buy ATS Corp (ATS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

29.880

1 Day change

1.94%

52 Week Range

32.730

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: technicals are soft and the stock is trading below the key pivot (28.759) ahead of earnings.
No Intellectia buy signals (AI Stock Picker/SwingMax), removing a key “act now” confirmation.
Options positioning is extremely call-skewed, but actual volume is tiny—sentiment looks optimistic, yet not strongly “confirmed” by liquidity.
With earnings (QDEC 2025) due pre-market 2026-02-04, the near-term move is event-driven; the setup is not favorable for a forced immediate entry.

Technical Analysis

Trend/price positioning: Pre-market 28.16 is below the pivot (28.759), implying a near-term bearish/neutral bias.
Momentum: MACD histogram -0.228 (below zero) with negative contraction—downtrend pressure is easing but not reversed.
RSI: RSI_6 at 39.625 (neutral-to-weak), consistent with a mildly oversold/soft tape rather than a strong rebound signal.
Moving averages: Converging MAs suggest consolidation; no clear upside trend confirmation.
Levels to watch: Support S1 27.797 then S2 27.202; Resistance R1 29.722 then R2 30.317. A convincing buy setup would likely require reclaiming 28.759 and holding above ~29.72.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning: Put/Call OI ratio 0.03 (puts 5 vs calls 183) = very call-heavy skew (bullish positioning).
Activity: Total volume is only 3 contracts (puts 3, calls 0) — sentiment signal is low-confidence due to minimal liquidity.
Volatility: IV30 ~51.5 vs HV ~45.56 (IV > realized), suggesting the market is pricing elevated move expectations (consistent with earnings/event risk).
IV rank/percentile: IV rank ~14.16 and IV percentile ~44.8 — not an extreme volatility bid relative to its own history.

Technical Summary

dotted line Image

Sell

1

Buy

10

Positive Catalysts

- Earnings catalyst imminent (QDEC 2025 earnings on 2026-02-04 pre-market; Street EPS est ~0.30): a beat/raise could quickly re-rate the stock.
- Revenue growth remains strong: 2026/Q2 revenue +18.88% YoY.
- Analyst stance skews positive overall: TD Buy (C$48), Scotiabank Outperform (C$47), JPM Neutral but raised PT ($35).

Neutral/Negative Catalysts

- Technical setup is not currently “buy-now”: price below pivot with MACD still negative.
- Profitability shock in latest reported quarter: 2026/Q2 net income and EPS fell sharply YoY (suggesting either heavy charges, margin pressure below operating line, or other non-recurring impacts).
- No supportive near-term flow signals: hedge funds neutral, insiders neutral; no notable buying pressure flagged.
- No recent news catalysts in the past week to support an immediate upside thesis.

Financial Performance

Latest quarter: 2026/Q2.
Revenue: 728.456M, +18.88% YoY (strong top-line growth).
Gross margin: 29.91%, +1.22% YoY (slight improvement at the gross level).
Net income: 33.679M, -3896.96% YoY; EPS: 0.34, -3500.00% YoY (major profitability deterioration vs prior-year comp, a key red flag until explained/normalized).
Takeaway: Growth is solid, but earnings quality/consistency is the main concern heading into the next print.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch